Treatment of the underlying condition predisposing to itch is essential to reduce recurrence in lichen simplex. Often patients find no reprieve from lichen simplex without targeted pharmacotherapy (e.g. topical corticosteroids).

2023年8月7日 · Treatment of lichen simplex chronicus may include the following: occlusion of the area; topical anti-inflammatory therapies such as corticosteroids (high-potency versions may be used for 3 weeks at a time for thicker plaques/lesions); topical emollients; antibiotics if infection is highly likely or present, especially if immunosuppressant drug ...

2024年9月6日 · Treatment is aimed at reducing pruritus and minimizing existing lesions because rubbing and scratching cause lichen simplex chronicus. Location, lesion morphology, and extent of the...

2019年10月10日 · Neurodermatitis, also called lichen simplex chronicus, is an itchy skin condition that is most active when you are relaxing. Learn more about how it looks and how you treat it.

2025年1月6日 · How is lichen simplex treated? There are a variety of ways to treat lichen simplex. Anti-inflammatory medications such as topical steroids can be prescribed to reduce itching and inflammation. Topical salicylic acid, which can loosen the thickened skin, may also be prescribed.

Treatment is directed at the initial cause of the itch and includes education and behavioral techniques to prevent scratching and rubbing, topical corticosteroids, and antihistamines.

2024年7月4日 · Treatment options include cotton gloves, moisturizers, or over-the-counter (OTC) antihistamines or steroid creams. This article describes the symptoms, causes, diagnosis, and treatment of lichen simplex chronicus, including how emotional stress can contribute.

Lichen Simplex Chronicus - Learn about the causes, symptoms, diagnosis & treatment from the Merck Manuals - Medical Consumer Version.

We conducted a systematic review of the literature to evaluate treatments for LSC and provide an evidence-based summary of the current treatments as well as highlight novel therapies. A total of 21 studies were included which comprised 682 patients with LSC involving various areas.

Therapy should be aimed at interrupting the itch–scratch cycle. 1 Systemic causes of itch should also be identified and addressed. In the authors’ experience, first-line treatment is topical high-potency corticosteroids. The literature also supports use of topical doxepin.